Cite
HARVARD Citation
Santinon, F. et al. (2020). Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis. Arthritis & rheumatology. 72 (4), pp. 576-587. [Online].